A Cost-Minimization Analysis of the Angio-Seal Vascular Closure Device Following Percutaneous Coronary Intervention

American Journal of Cardiology

Volumn 99, Issue 6, 2007, Pages 766-770

  Resnic, Frederic S ^a   Arora, Nipun ^a   Matheny, Michael ^a   Reynolds, Matthew R ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ARTICLE; CARDIOVASCULAR EQUIPMENT; COST MINIMIZATION ANALYSIS; ECONOMIC ASPECT; HOSPITAL COST; HUMAN; MONTE CARLO METHOD; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; VASCULAR ACCESS;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BOSTON; CASE-CONTROL STUDIES; COST SAVINGS; COST-BENEFIT ANALYSIS; FEMORAL ARTERY; HEMOSTATIC TECHNIQUES; HOSPITAL COSTS; HUMANS; MASSACHUSETTS; MODELS, STATISTICAL; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS;

EID: 33847619381     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.10.032     Document Type: Article

References (22)

1. Koreny M., Riedmuller E., Nikfardjam M., Siostrzonek P., and Mullner M. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. JAMA 291 (2004) 350-357
2. Nikolsky E., Mehran R., Halkin A., Aymong E.D., Mintz G.S., Lasic Z., Negoita M., Fahy M., Krieger S., Moussa I., et al. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol 44 (2004) 1200-1209
3. Applegate R.J., Sacrinty M.T., Kutcher M.A., Baki T.T., Gandhi S.K., Santos R.M., and Little W.C. Propensity score analysis of vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention 1998-2003. Catheter Cardiovasc Interv 67 (2006) 556-562
4. Resnic F.S., Blake G.J., Ohno-Machado L., Selwyn A.P., Popma J.J., and Rogers C. Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb-IIIa inhibitors. Am J Cardiol 88 (2001) 493-496
5. Sanborn T.A., Gibbs H.H., Brinker J.A., Knopf W.D., Kosinski E.J., and Roubin G.S. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty. J Am Coll Cardiol 22 (1993) 1273-1279
6. Condon J.V.J., Elsner G.B., Nootens M.T., Gowan S.A., Coverdale J., Linnemeier T.J., and Rothbaum D.A. Comparison of hemostasis time and vascular complications between the Angio-Seal hemostatic puncture closure device and manual pressure. Circulation 92 suppl (1995) I599
7. Amin F.R., Yousufuddin M., Stables R., Shamim W., Al-Nasser F., Coats A.J., Clague J., and Sigwart U. Femoral haemostasis after transcatheter therapeutic intervention: a prospective randomised study of the angio-seal device vs. the FemoStop device. Int J Cardiol 76 (2000) 235-240
8. Doneux P., Gach O., Martinez C., and Legrand V. Femoral puncture closure devices versus manual compression after percutaneous coronary interventions. Eur Heart J 22 suppl (2001) 216
9. Chevalier B., Lancelin B., Koning R., Henry M., Gommeaux A., Pilliere R., Elbaz M., Lefevre T., Boughalem K., Marco J., and Dupouy P. Effect of a closure device on complication rates in high-local-risk patients: results of a randomized multicenter trial. Catheter Cardiovasc Interv 58 (2003) 285-291
10. Boccalandro F., Assali A., Fujise K., Smalling R.W., and Sdringola S. Vascular access site complications with the use of closure devices in patients treated with platelet glycoprotein IIb/IIIa inhibitors during rescue angioplasty. Catheter Cardiovasc Interv 63 (2004) 284-289
11. Juergens C.P., Leung D.Y., Crozier J.A., Wong A.M., Robinson J.T., Lo S., Kachwalla H., and Hopkins A.P. Patient tolerance and resource utilization associated with an arterial closure versus an external compression device after percutaneous coronary intervention. Catheter Cardiovasc Interv 63 (2004) 166-170
12. Cura F.A., Kapadia S.R., L'Allier P.L., Schneider J.P., Kreindel M.S., Silver M.J., Yadav J.S., Simpfendorfer C.C., Raymond R.R., Tuzcu E.M., et al. Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade. Am J Cardiol 86 (2000) 780-782
13. Dangas G., Mehran R., Kokolis S., Feldman D., Satler L.F., Pichard A.D., Kent K.M., Lansky A.J., Stone G.W., and Leon M.B. Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol 38 (2001) 638-641
14. Applegate R.J., Grabarczyk M.A., Little W.C., Craven T., Walkup M., Kahl F.R., Braden G.A., Rankin K.M., and Kutcher M.A. Vascular closure devices in patients treated with anticoagulation and IIb/IIIa receptor inhibitors during percutaneous revascularization. J Am Coll Cardiol 40 (2002) 78-83
15. Assali A.R., Sdringola S., Moustapha A., Ghani M., Salloum J., Schroth G., Fujise K., Anderson H.V., Smalling R.W., and Rosales O.R. Outcome of access site in patients treated with platelet glycoprotein IIb/IIIa inhibitors in the era of closure devices. Catheter Cardiovasc Interv 58 (2003) 1-5
16. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
17. Pauker S.G., and Kassirer J.P. The threshold approach to clinical decision making. N Engl J Med 302 (1980) 1109-1117
18. Briggs A., Sculpher M., and Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ 3 (1994) 95-104
19. Critchfield G.C., and Willard K.E. Probabilistic analysis of decision trees using Monte Carlo simulation. Med Decis Making 6 (1986) 85-92
20. Halpern E.F., Weinstein M.C., Hunink M.G.M., and Gazelle G.S. Representing both first- and second-order uncertainties by Monte Carlo simulation for groups of patients. Med Decis Making 20 (2000) 314-322
21. Kugelmass A.D., Cohen D.J., Brown P.P., Simon A.W., Becker E.R., and Culler S.D. Hospital resources consumed in treating complications associated with percutaneous coronary interventions. Am J Cardiol 97 (2006) 322-327
22. Cohen D.J., Lincoff A.M., Lavelle T.A., Chen H.L., Bakhai A., Berezin R.H., Jackman D., Sarembock I.J., and Topol E.J. Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial. J Am Coll Cardiol 44 (2004) 1792-1800